"US Intelligence Warns of WuXi AppTec Sharing Client Data with China, Posing Supply-Chain Risks for Drug Companies"

U.S. intelligence officials briefed senators on concerns that Chinese pharmaceutical firm WuXi AppTec had transferred U.S. intellectual property to Beijing without consent, potentially for use by China's military. The proposed legislation aims to restrict U.S. government funds going to Chinese companies engaged in such activities. WuXi AppTec denied unauthorized transfers and stated compliance with U.S. regulations. The briefing coincided with the Senate's consideration of a bill restricting business with Chinese biotech companies on national security grounds, and led to lobbying group BIO reversing its opposition to the bill, citing national security concerns.